Skip to main content
New Year’s Sale — Build a balanced news diet with 40% off Vantage
Published loading...Updated

Lmu Spin-Off Amplifold Achieves New Financing for the Development of Better Rapid Tests

Summary by bionity.com
Amplifold GmbH, a spin-off from LMU, has completed a seed financing round of five million euros. The start-up is developing a technology that uses DNA origami nanostructures to significantly increase the sensitivity of commercial lateral flow tests (LFAs).
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.Cross Cancel Icon

2 Articles

analytica-world.comanalytica-world.com
Reposted by
bionity.combionity.com

Amplifold GmbH, a spin-off from LMU, has completed a seed financing round of five million euros. The start-up is developing a technology that uses DNA origami nanostructures to significantly increase the sensitivity of commercial lateral flow tests (LFAs).

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

bionity.com broke the news in on Wednesday, January 7, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal